Drug therapy: antiplatelet therapy (second of two parts).
D000368:Aged; D001166:Arteriovenous Shunt, Surgical; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008297:Male; D008833:Microcirculation; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control
D003911:Dextrans; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone